SMTL ID : 9lo7.1 (1 other biounit)

The crystal structure of PDE4D with 2317b

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION

ZN.1: 5 residues within 4Å: Chain A: H.164, H.200, D.201, D.318 Ligands: MG.2 6 PLIP interactions: 4 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:H.164, A:H.200, A:D.201, A:D.318, H2O.1, H2O.2

1 x MG: MAGNESIUM ION

MG.2: 2 residues within 4Å: Chain A: D.201 Ligands: ZN.1 6 PLIP interactions: 1 interactions with chain A, 5 Ligand-Water interactions Metal complexes: A:D.201, H2O.1, H2O.1, H2O.1, H2O.2, H2O.4

1 x 01: methyl 4-[[2-[4-[bis(fluoranyl)methoxy]-3-(cyclopropen-1-ylmethoxy)phenyl]-6-oxidanyl-1-benzofuran-7-yl]oxy]-1~{H}-pyrrole-2-carboxylate

01.3: 14 residues within 4Å: Chain A: Y.159, H.160, M.273, N.321, P.322, Y.329, W.332, T.333, I.336, F.340, M.357, S.368, Q.369, F.372 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:Y.159, A:M.273, A:I.336, A:M.357, A:F.372 Hydrogen bonds: A:Q.369 Water bridges: A:N.209

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, F. et al., Structure-Based Optimization of Moracin M as Potent and Selective PDE4 Inhibitors with Antipsoriasis Effects. J.Med.Chem. (2025)

Release Date

2025-03-26

Peptides

3',5'-cyclic-AMP phosphodiesterase 4D: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

3',5'-cyclic-AMP phosphodiesterase 4D

Related Entries With Identical Sequence